Changes in Outpatient Use and Dosage of Tirzepatide in Japan Based on National Prescription Data

Tirzepatide, available in six strengths, is approved in Japan for treating type 2 diabetes.

• Japanese studies have focused on tirzepatide's efficacy, safety, and patient-level maintenance doses.
• There is a lack of data on national dispensing patterns and changes in product-strength mix.
• The examination aimed to determine if increased quantities of claims correlate with changes in outpatient dispensing structures.

Simplified